Atherogenic dyslipidemia is a critical factor in developing CVD related to Metabolic Syndrome. While atherogenic dyslipidemia plays a prominent role in the development of atherosclerosis, endothelial dysfunction works alongside atherogenic dyslipidemia to contribute to the development of CVD as endothelial dysfunction also promotes atherosclerotic plaque development. This effect may provide to be synergistic in patients with MS, as endothelial dysfunction is predominantly found in this population. Other modes of action exist in MS which directly influence atherogenic dyslipidemia.
High-impact journals are those considered to be highly influential in their respective fields. The impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the average number of citations to recent articles published in science and social science journals in a particular year or period, and is frequently used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founder of the Institute for Scientific Information.The impact factor of a journal is evaluated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Last date updated on September, 2014